CAS is launching a collaboration with Mana.bio to enrich their proprietary database to fuel its AI engine, with an expected 70% reduction in resources allocated to molecular data acquisition and preparation.
Mana.bio integrates CAS chemical substance data into its novel drug delivery AI platform
CAS applies AI-driven approach in collaboration with INPI Brazil to transform patent examinations
CAS has completed a project with The National Institute of Industrial Property (INPI) of Brazil for an enhanced examination workflow solution for chemistry patent applications using a unique blend of technology, artificial intelligence, data, and expertise. The new solution reduced application examination times by up to 50%, and helped to reduce their multi-year application backlog.
World’s most trusted source for chemistry information, CAS, launches major biology expansion
The CAS SciFinder Discovery Platform redefines its role in drug discovery with the inclusion of unique biosequence data collection and capabilities.
April19 and CAS collaborate to accelerate real-world application of AI to discovery of novel mental health therapeutics
April19 and CAS collaborate to accelerate real-world application of AI to discovery of novel mental health therapeutics. Pairing curated data and advanced analytics with deep learning approach to drug discovery shortens pipeline and reduces cost.
CAS Launches Significant Enhancement to Predictive Retrosynthetic Capabilities in SciFinderⁿ
CAS announces significant enhancements to the predictive retrosynthetic capabilities in SciFinderⁿ. The enhanced platform uses state-of-the-art AI technology to improve both accuracy and innovativeness of predicted results.
CAS launches new brand reflecting strategic evolution to empower smarter science
CAS launched a new brand reflecting the broadening scope of its solutions and capabilities critical to advancing scientific discovery. This new brand mirrors an on-going evolution to enable new and smarter uses of scientific information as a partner to R&D leaders pursuing more efficient, collaborative, and customized innovation models.
CAS Common Chemistry™ expands collection of publicly available chemical information
CAS has expanded the open access Common Chemistry resource to nearly 500,000 substances from CAS REGISTRY®. The collection represents substances commonly found in consumer products, regulatory lists, and introductory chemistry curricula.
New AI-Enabled Virtual Screening Tool Identifies Most Promising Approved Drugs for Success in Treating COVID-19
WorldQuant Predictive (WQP) and CAS have partnered to develop a groundbreaking methodology that can save time and lives by helping researchers rapidly prioritize the most promising drug candidates to treat COVID-19 and other critical diseases.
Scilligence Partners with CAS to Optimize R&D Informatics Workflows with Scientist-Curated Data
Scilligence, a provider of web-based informatics solutions for R&D, has partnered with CAS to enable direct access to CAS scientific content through the Scilligence informatics platform. This partnership builds on a previous collaboration by streamlining additional workflow scenarios. Users can now access CAS REGISTRY® data directly from Scilligence ELN and Scilligence Inventory.